Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SECUKINUMAB for Pustular psoriasis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 317 adverse event reports in the FDA FAERS database where SECUKINUMAB was used for Pustular psoriasis.

Most Reported Side Effects for SECUKINUMAB

Side Effect Reports % Deaths Hosp.
Drug ineffective 27,434 18.1% 1,304 2,864
Psoriasis 21,976 14.5% 444 2,289
Pain 15,244 10.1% 1,659 3,575
Arthralgia 13,769 9.1% 1,652 3,157
Fatigue 9,406 6.2% 1,796 3,142
Psoriatic arthropathy 8,900 5.9% 1,846 2,614
Pruritus 8,755 5.8% 1,088 1,921
Malaise 8,570 5.7% 1,593 3,029
Rash 8,023 5.3% 1,814 2,489
Condition aggravated 7,536 5.0% 1,526 2,225
Diarrhoea 7,131 4.7% 1,522 2,578
Nasopharyngitis 7,022 4.6% 1,438 2,092
Pain in extremity 6,700 4.4% 1,059 1,874
Headache 6,344 4.2% 1,496 2,466
Joint swelling 5,700 3.8% 1,761 2,440

Other Indications for SECUKINUMAB

Psoriasis (58,471) Product used for unknown indication (42,781) Psoriatic arthropathy (38,507) Ankylosing spondylitis (12,393) Rheumatoid arthritis (3,334) Hidradenitis (1,484) Axial spondyloarthritis (924) Spondylitis (257) Arthritis (226) Spondyloarthropathy (172)

Other Drugs Used for Pustular psoriasis

APREMILAST (349) ADALIMUMAB (207) METHOTREXATE (159) CYCLOSPORINE (157) ETANERCEPT (146) INFLIXIMAB (144) ACITRETIN (129) USTEKINUMAB (120) EFALIZUMAB (101) IXEKIZUMAB (81)

Related Pages

SECUKINUMAB Full Profile All Pustular psoriasis Drugs SECUKINUMAB Demographics SECUKINUMAB Timeline